Electrocardiographic, enzymatic, and morphologic signs of myocardial ischemic injury following coronary occlusion have previously been shown to be ameliorated by reducing myocardial oxygen requirements, and/or by increasing the availability of oxygen as well as of substrates for anaerobic ATP production. Since hyaluronidase increases diffusion through the extracellular space and may facilitate delivery of substrates to ischemic cells, the influence of its administration on the size of experimentally produced infarcts was studied. In 14 control dogs epicardial electrocardiograms were taken in 10-15 sites on the anterior surface of the left ventricle before and after occlusion of the left anterior descending coronary artery. Twenty-four hours later, transmural specimens were obtained from the same sites from which electrocardiograms had been recorded, and were analyzed for creatine phophokinase (CPK) activity, for histologic changes, and glycogen content. In control dogs, sites exhibiting S-T-segment elevation 15 min after occlusion showed early structural signs of necrosis and glycogen depletion in 97% of specimens taken after 24 hours. The relationship between S-T-segment elevation at 15 min (mv) and CPK activity 24 hours later (IU/mg protein) was log CPK =-0.061 S-T + 1.26. Hyaluronidase (225 u/kg) was given to 15 dogs; no hemodynamic changes occurred but the depression of CPK activity was reduced following occlusion; log CPK = -0.024 S-T + 1.28. Similarly, only 55% of sites that showed S-T-segment elevation prior to hyaluronidase administration exhibited histologic signs of early infarcts and glycogen depletion 24 
IN 1959, Oliveira et al. ' described reductions in S-T-segment elevation in experimental infarcts as well as in patients with acute myocardial infarction following the administration of hyaluronidase, attributing these effects to the decrease in myocardial edema. Other investigators subsequently confirmed this observation.2 3 Recently we described methods for examining the extent and severity of myocardial ischemic injury following coronary occlusion and demonstrated that various pharmacologic and hemodynamic interventions may alter infarct size substantially. [4] [5] [6] [7] The purpose of this investigation was to utilize these methods in order to study the effects of hyaluronidase on the size of an experimentally produced myocardial infarct.
Methods
Studies were carried out in 35 dogs weighing between 17 and 25 kg. They were anesthetized with sodium thiamylal (25 mg/kg) with respiration maintained by a Harvard respirator. The heart was exposed through a left thoracotomy and suspended in a pericardial cradle. The left anterior descending coronary artery (LAD) or its apical branch was dissected free from the adjacent tissue and occluded permanently with a ligature or intermittently with a Schwartz intracranial arterial clamp. As previously described,4 5 7 epicardial electrocardiograms were obtained from 10-15 sites on the anterior surface of the left ventricle distributed in areas supplied by the occluded artery as well as in areas remote to it and presumably adequately perfused. The animals were divided into two groups.
Control Group I: Occlusion Alone
Occlusion alone, without any drug intervention, was performed in 14 dogs. Epicardial electrocardiograms were taken prior to and 5, 10, 15, 20, 30 and 45 min following occlusion. The thorax was then closed and the dogs were allowed to awaken. Twenty-four hours later they were reanesthetized and the heart was excised. Immediately after the excision transmural specimens were taken for analysis of creatine phosphokinase (CPK) activity and histologic structure at the sites from which electrocardiograms had previously been recorded. During The predictive value of S-T-segment elevation to CPK activity and histologic structure 24 hours later was established in this group. Sites remote from the occluded region with normal S-T segments (0-2 mv elevation) showed normal CPK activity, 18.8 ± 0.4 (mean + SEM) LU/mg of protein (14 dogs, 47 specimens). Log CPK activity 24 hours after ligation was inversely proportional to S-T-segment elevation 15 min after occlusion: log CPK = -0.061 S-T + 1.26 (r 0.79; N = 102 specimens). Thus, the higher the S-T segment 15 min after occlusion, the lower the CPK activity 24 hours later (figs. 1, 2) .
Of the sites with S-T-segment elevations exceeding 2 mv 15 min after occlusion, 97% (51 of 53) exhibited early signs of myocardial 25- necrosis. These findings included a more pronounced eosinophilic appearance, loss of muscular cross striations, karyolysis, karyorrhexis, and leukocyte cell infiltration ( fig. 2;  table 1 ). On the other hand, 96% (27 of 28 specimens) of sites with normal S-T segments (0-2 mv elevation) showed normal myocardial structure ( fig. 2; table 1) . Also, the sites with normal S-T segments showed preservation of glycogen granules in 96% (27 of 28 sites), 15 whereas 97% (51 of 53) of sites with S-T segment elevation exceeding 2 mv showed glycogen depletion. In this group in which hyaluronidase was injected intravenously 30 min after occlusion, the sum of S-T-segment elevations (E S-T) at all sites at which epicardial electrocardiograms were taken just prior to and 15 min following hyaluronidase administration decreased from 59.6 ± 2.8 to 29.0 + 8.1 mv (P<0.05) ( fig. 3, left) . The number of sites that showed S-T-segment elevation exceeding tSignificantly greater than group I (P < 0.00a).
4.8 + 1.3 (P < 0.05) ( fig. 3, right) . In comparison, in the control dogs there was no statistical change in IS-T and NS-T during the same time interval, i.e. between 30 and 45 min after occlusion (IS-T from 52.7 ± 11.8 to 57.6 + 13.1 mv and NS-T from 5.8 ± 0.8 to 6.0 + 1.0). Heart rate, systemic arterial pressure, and left atrial pressure remained un- Twenty-four hours later CPK activity in sites with normal S-T segments in dogs that were treated with hyaluronidase was not significantly different from the normal group (19.6 + 0.8, N = 26 as compared to 18.8 + 0.4, N =47 in group I). However, CPK activity was less depressed than expected (from the results in group I) in sites which were elevated prior to hyaluronidase administration. Moreoever, some border-zone sites which had S-T-segment elevations prior to hyaluronidase administration subsequently showed completely normal CPK activity and histology ( fig. 4; table I ). The reduced depression of CPK activity subsequent to the administration of hyaluronidase 30 min following occlusion is reflected in the slope of the line relating S-Tsegment elevation 15 min after occlusion and prior' to hyaluronidase administration to the CPK activity 24 hours later; log CPK= -0.025 S-T + 1.29 (r = 0.6; N = 47; fig. 1 pathologic S-T-segment elevations showed glycogen depletion.
Subgroup B
In this subgroup two successive occlusions were carried out, the first without drug intervention and the second after hyaluronidase pretreatment. IS-T was significantly lower during the second occlusion than the first, the average IS-T decreasing from 61.4 ± 13.3 mv 15 min after the first occlusion to 36.1 + 11.1 mv (P<0.01) 15 min after the second occlusion ( fig. 3, left) . Similarly, NS-T decreased from 7.9 + 0.7 after the first occlusion to 5.1 + 1.1 (P<0.05) after the second occlusion ( fig. 3, right ). An example showing the decrease in IS-T and the area of S-Tsegment elevation is illustrated in figure 5 . Heart rate, systemic arterial pressure, and left atrial pressure were not altered by hyaluronidase administration. At each site CPK activity 24 hours after coronary occlusion was compared to the S-T-segment elevation 15 min after occlusion alone (first occlusion). Figure  1 shows that, just as in subgroup A, there was less CPK depression than that expected from the observations in the control group. Histologically, 1009, (11 of 11) sites with normal S-T segments showed normal histology and preservation of glycogen. However, 35% (12 of 35) of sites with S-T-segment elevations exceeding 2 mv after the first occlusion were protected from undergoing necrosis and their glycogen stores were maintained ( ischemic hearts this dose did not alter heart rate (N =15), systemic arterial blood pressure (N =15), left atrial pressure (N = 8), left ventricular systolic and end-diastolic pressures (N = 6), and peak dP/dt (N = 6).
In four additional animals with ischemic hearts, 500 u/kg also failed to alter any of these variables.
Discussion
The mortality of patients with acute myocardial infarction who develop cardiogenic shock is prohibitive.8 Autopsy studies have revealed that cardiogenic shock is uniformly associated with large infarcts9 and, since it has been shown that infarct size can be influenced markedly by pharmacologic interventions as well as by the hemodynamic state following coronary occlusion,4 efforts have been made to establish the conditions which can decrease the size of the potential infarct. It has been found that interventions which improve myocardial oxygen balance such as propranolol and practolol, elevation of arterial pressure, and intraaortic balloon counterpulsation do reduce the extent and magnitude of myocardial ischemic injury and/ or necrosis.4 6 7,10,1 Moreover, the infusion of a combination of glucose, insulin, and potassium, and to a lesser extent glucose alone, also limit the development of myocardial necrosis, probably by enhancing anaerobic energy production. 5 The administration of hyaluronidase offers several potential advantages compared to the above-mentioned interventions: (1) only after frequent exposure, and may be avoided completely if a skin test is performed. (6) Finally, in terms of effectiveness in reducing myocardial necrosis following coronary ligation, hyaluronidase compares favorably with other interventions such as propranolol, glucose, and glucose-insulin-potassium. This decrease in damage to the myocardium following coronary occlusion due to hyaluronidase is reflected in the substantial reduction in the magnitude and extent of the area of S-T-segment elevation (YS-T decreased by 41% and NS-T by 46%), by strikingly reduced depression of CPK activity, by a much smaller area of histologic damage, and by preservation of myocardial glycogen granules in sites which were expected to undergo necrosis on the basis of observations in control dogs.
The mechanism of action of hyaluronidase in reducing infarct size is not known. Oliveiral postulated that it produced a decrease in interstitial myocardial edema and subsequently showed a decrease in total myocardial water after hyaluronidase administration.'8 However, the decrease in edema may not be the cause but the consequence of less extensive myocardial injury.
It is suggested that the action of hyaluronidase is based on its postulated effect on the transport of energy-producing nutrients from the bloodstream to the myocardial cells. It has been shown previously that increasing coronary perfusion pressure reduces the area of ischemic injury.4' 6 This action may be explained by postulating that this intervention increases the supply of nutrients through the collateral vessels as well as the pressure and concentration gradients across the wall of the capillaries, thus augmenting the transport of oxygen and substrates to the interstitial space. The infusion of the combination of glucoseinsulin-potassium,5 in addition to increasing the quantity of substrate available for anaerobic glycolysis, also accelerates the transport of glucose into the cell through the action of insulin. It is known that hyaluronidase depolymerizes hyaluronic acid and that it thereby facilitates the transport of a variety of substances through the interstitial spaces '9' 20 and increases capillary permeability.21 This action may be particularly important in the presence of coronary occlusion in which nutrients have to be transported through longer extravascular pathways than when the coronary arteries are patent. Using a histologic staining method for hyaluronic acid (Alcian green) we have shown that 24 hours after occlusion the quantity of positively stained material in the interstitial tissue of the heart is clearly reduced by the administration of hyaluronidase. This observation is consistent with the hypothesis that hyaluronidase acts through its depolymerizing property.
In conclusion, though its mechanism of action is open to speculation, hyaluronidase was shown to protect the myocardium from undergoing extensive ischemic injury and consequent necrosis following coronary occlusion. This action is possible without apparent deleterious side effects and suggests that this substance may be of value in the treatment of patients with impending myocardial infarction, or early after coronary occlusion.
